Game-Changing Medicare Insights Across the Product Lifecycle
We actively immerse ourselves in the world of Medicare claims data, gaining a deep understanding of diseases, treatments, healthcare providers, and markets. This expertise enables us to enhance patient care and boost return on investment for pharmaceutical and biotech companies.
Solutions that Deliver Impactful Product Life Cycle Insights.
CareSet's census-level Medicare data and expertise streamline early drug development by identifying indications, understanding payors, and informing pre-clinical decisions for strategic pharmaceutical progress.
CareSet streamlines clinical operations and patient enrollment for manufacturers, enhancing decentralized trials and ethnic diversity.
In late-stage clinical development, CareSet's expertise in patient journey mapping, targeting thought leaders, and MarketView insights crucially aids pharmaceutical companies in market valuation, pricing strategies, and brand management.
CareSet equips commercial teams with essential data on market trends, healthcare provider management, and patient transitions, enhancing adoption strategies.
Our expertise in Medicare claims data enables pharmaceutical companies to navigate Part D regulations, manage rebates with discarded drug data analysis, and ensure compliance with regulations using LIS data.
Solutions that Deliver Impactful Product Lifecycle Insights.
Pre-Clinical Strategy
CareSet's census-level Medicare data and expertise streamline early drug development by identifying indications, understanding payors, and informing pre-clinical decisions for strategic pharmaceutical progress.
Clinical Trial Recruitment
CareSet streamlines clinical operations and patient enrollment for manufacturers, enhancing decentralized trials and ethnic diversity.
Market Access (Late Stage Clinical Development and Pre-launch Strategy)
In late-stage clinical development, CareSet's expertise in patient journey mapping, targeting thought leaders, and MarketView insights crucially aids pharmaceutical companies in market valuation, pricing strategies, and brand management.
Commercial Operations (Sales Excellence and Effectiveness)
CareSet equips commercial teams with essential data on market trends, healthcare provider management, and patient transitions, enhancing adoption strategies.
Regulatory
Our expertise in Medicare claims data enables pharmaceutical companies to navigate Part D regulations, manage rebates with discarded drug data analysis, and ensure compliance with regulations using LIS data.
Smarter Insights: Navigating Pharma's Drug Lifecycle with CareSet
CareSet teams up with pharma companies, offering smart, data-driven support at every stage of a drug's journey. We blend innovation with practicality, providing Medicare expertise and insights that make a real difference in navigating the complex drug lifecycle.
Pre-clinical Strategy
- Treatment Journey
- Disease Benchmark Impact
- MarketView
- Disease Benchmark Impact
Clinical Trial Recruitment
- KOL Targeting
- Health Equity
Market Access
- Treatment Journey
- Diagnostic Journey
- Market View by Pharmacy Type
- Part D Payer and Plan-Level Data
- HEOR/Medical Value Liaisons Dataset
- Medical Science Liaison (MSLs) Physician Profiles
Commercial Operations
- Monthly Alerts
- Treatment Journey
- Diagnostic Journey
- MarketView
- Targeting
- Referrals
- Affiliations
- Out of Pocket Tracker
Regulatory Affairs
- IRA Part D Spending Dashboard
- Biologic Discard Rebate (HR3684)
- LIS/Catastrophic
Smarter Insights: Navigating Pharma's Drug Lifecycle with CareSet
CareSet teams up with pharma companies, offering smart and data-driven support at every stage of a drug's journey. We blend innovation with practicality, providing Medicare expertise and insights that make a real difference in navigating the complex drug lifecycle.
Smarter Insights: Navigating Pharma's Drug Lifecycle with CareSet
CareSet teams up with pharma companies, offering smart, data-driven support at every stage of a drug's journey. We blend innovation with practicality, providing Medicare expertise and insights that make a real difference in navigating the complex drug lifecycle.
Pre-clinical Strategy
- Treatment Journey
- Disease Benchmark Impact
- MarketView
- Disease Benchmark Impact
Clinical Trial Recruitment
- KOL Targeting
- Health EquityMarketView
Market Access
- Part D Payer and Plan-Level DataMarketView
- HEOR/Medical Value Liaisons DatasetDisease Benchmark Impact
- Medical Science Liaison (MSLs) Physician Profiles
- Treatment Journey
- Diagnostic Journey
- Market View by Pharmacy Type
Commercial Operations
- Monthly Alerts
- Treatment Journey
- Diagnostic Journey
- MarketView
- Targeting
- Referrals
- Affiliations
- Out of Pocket Tracker
Regulatory Affairs
- IRA Part D Spending Dashboard
- Biologic Discard Rebate (HR3684)
- LIS/Catastrophic
Pre-clinical Strategy
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
MarketView: Insights for market sizing, forecasting by indication, treatment, and brand.
Disease Benchmark Impact: Assessment of disease impact, aiding in healthcare challenges.
Clinical Trial Recruitment
KOL Targeting: Streamline clinical operations for manufacturers, enhancing decentralized trials by leveraging investigators' networks and proximity alerts within a 4-hour drive.
Health Equity: Use race, ethnicity and income data of Medicare patients to help with clinical trial recruitment.
Market Access
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
Market View by Pharmacy Type: Insights into pharmacy sales, payments, and PBM contracting.
Part D Payer and Plan-Level Data: Regional plan utilization insights by plan, provider, even for blocked accounts.
HEOR: Medical Value Liaisons Dataset.Medical Science Liaison (MSLs): Physician profiles.
Commercial Operations
Monthly Alerts: Physician-level alerts for field decision-making.
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Journey to diagnosis.
MarketView: Monthly market share reports by indication, treatment, and brand.
Targeting: Activity data for prescriptions, identifying managing HCPs and their affiliated HCOs.
Referrals: Track healthcare providers referring patients to specialists.
Affiliations: Uncover financial relationships between providers.
Out-of-Pocket Tracker: Identify brand-eligible patients while controlling out-of-pocket costs.
Regulatory Affairs
IRA Part D Spending Dashboard: Up-to-date Part D gross expenditure to identify high-cost drugs.
Biologic Discard Rebate (HR3684): Cost accrual for national discarded biologic medications reported by brand for rebate management.
LIS/Catastrophic: Utilizing LIS data for targeting and supporting regulatory compliance.
Pre-clinical Strategy
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
MarketView: Insights for market sizing, forecasting by indication, treatment, and brand.
Disease Benchmark Impact: Assessment of disease impact, aiding in healthcare challenges.
Clinical Trial Recruitment
KOL Targeting: Streamline clinical operations for manufacturers, enhancing decentralized trials by leveraging investigators' networks and proximity alerts within a 4-hour drive.
Health Equity: Use race, ethnicity and income data of Medicare patients to help with clinical trial recruitment.
Market Access
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
Market View by Pharmacy Type: Insights into pharmacy sales, payments, and PBM contracting.
Part D Payer and Plan-Level Data: Regional plan utilization insights by plan, provider, even for blocked accounts.
HEOR: Medical Value Liaisons Dataset.Medical Science Liaison (MSLs): Physician profiles.
Commercial Operations
Monthly Alerts: Physician-level alerts for field decision-making.
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Journey to diagnosis.
MarketView: Monthly market share reports by indication, treatment, and brand.
Targeting: Activity data for prescriptions, identifying managing HCPs and their affiliated HCOs.
Referrals: Track healthcare providers referring patients to specialists.
Affiliations: Uncover financial relationships between providers.
Out of Pocket Tracker: Identify brand eligible patients while controlling out-of-pocket costs.
Regulatory Affairs
IRA Part D Spending Dashboard: Up-to-date Part D gross expenditure to identify high-cost drugs.
Biologic Discard Rebate (HR3684): Cost accrual for national discarded biologic medications reported by brand for rebate management.
LIS/Catastrophic: Utilizing LIS data for targeting, supporting regulatory compliance.
Pre-clinical Strategy
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
MarketView: Insights for market sizing, forecasting by indication, treatment, and brand.
Disease Benchmark Impact: Assessment of disease impact, aiding in healthcare challenges.
Market Access (Late Stage Clinical Development and Pre-launch Strategy)
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
Market View by Pharmacy Type: Insights into pharmacy sales, payments, and PBM contracting.
Part D Payer and Plan-Level Data: Regional plan utilization insights by plan, provider, even for blocked accounts.
HEOR: Medical Value Liaisons Dataset.
Medical Science Liaison (MSLs): Physician profiles.
Diagnostic Journey: Patient journey to diagnosis.
Market View by Pharmacy Type: Insights into pharmacy sales, payments, and PBM contracting.
Part D Payer and Plan-Level Data: Regional plan utilization insights by plan, provider, even for blocked accounts.
HEOR: Medical Value Liaisons Dataset.
Medical Science Liaison (MSLs): Physician profiles.
Clinical Trial Recruitment
KOL Targeting: Streamline clinical operations for manufacturers, enhancing decentralized trials by leveraging investigators' networks and proximity alerts within a 4-hour drive.
Health Equity: Use race, ethnicity and income data of Medicare patients to help with clinical trial recruitment.
Health Equity: Use race, ethnicity and income data of Medicare patients to help with clinical trial recruitment.
Regulatory Affairs
IRA Part D Spending Dashboard: Up-to-date Part D gross expenditure to identify high-cost drugs
Biologic Discard Rebate (HR3684): Cost accrual for national discarded biologic medications reported by brand for rebate management.
LIS/Catastrophic: Utilizing LIS data for targeting, supporting regulatory compliance.
Biologic Discard Rebate (HR3684): Cost accrual for national discarded biologic medications reported by brand for rebate management.
LIS/Catastrophic: Utilizing LIS data for targeting, supporting regulatory compliance.
Connect with CareSet Today
Let's start a conversation to explore how CareSet's comprehensive healthcare data insights can empower your business for data-driven success.
Category
Blog Post Title 01
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
April 8, 2024
7 min read
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CareSet decodes Medicare claims data, enhancing healthcare insights to elevate standards of care for patients and populations.
Copyright © CareSet 2024. All Rights Reserved.
